Type of Deal |
Value |
Acquirer |
Target |
Adviser to acquirer (tax) |
Adviser to target (tax) |
Acquisition |
$1.1 billion |
Permira Funds |
Atrium Innovations |
Skadden, Arps, Slate, Meagher & Flom - Katherine Bristor, Brian Krause |
|
Acquisition |
Undisclosed |
Yucaipa |
Fresh & Easy (Tesco) |
Davis Polk & Wardwell - Kathleen Ferrell |
|
Acquisition |
Undisclosed |
KKR |
Gland Pharma Limited |
Amarchand & Mangaldas; Simpson Thacher & Bartlett, EY |
EY; KPMG |
Acquisition/stake sale |
Undisclosed |
Religare |
Religare Macquarie Wealth Management (Macquarie Group) |
Vaish Associates |
Amarchand & Mangaldas |
Type of Deal |
Value |
Issuer/Borrower |
Lead managers/arrangers |
Adviser to issuer/borrower (tax) |
Adviser to lead managers (tax) |
Convertible notes offering |
$1.25 billion |
Yahoo! |
JP Morgan Securities; Goldman, Sachs |
Davis Polk & Wardwell - Rachel Kleinberg, Catherine Paskoff Chang, Vinay Prabhakar |
|
SEC-registered notes offering |
$350 million |
Aon |
Morgan Stanley; Merrill Lynch, Pierce, Fenner & Smith; Deutsche Bank; JP Morgan |
Davis Polk & Wardwell - Samuel Dimon, Jonathan Cooklin |
|
Common stock offering |
$90 million |
Cardiovascular Systems |
Merrill Lynch, Pierce, Fenner & Smith |
Fredrikson & Byron |
Davis Polk & Wardwell - Rachel Kleinberg, Catherine Paskoff Chang |